CMV Immune Responses and Cognitive Impairment in People with HIV.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 42049391.
- Also identified by DOI 10.1093/infdis/jiag239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
People with HIV (PWH) have an earlier occurrence of aging complications, including cognitive impairment (CI). Chronic immune activation from cytomegalovirus (CMV) may contribute to increased inflammation and CI. We explored this association using several measures of CMV immune response among PWH. In a case-control design, we compared CMV IgG, ELISpot, and flow cytometry between cases (subsequent CI) and controls (no CI). Baseline CMV IgG, CMV ELISpot, or flow measures were not associated with subsequent CI. This exploratory analysis supports larger studies using more nuanced immunophenotyping to clarify relationship between CMV and development of CI in PWH.